<p>H:/dar/1ntenvoven/NRPortbl/DCC/DAR/8802933_ l.DOC.6/11/2015 Abstract S1P receptor modulators are administered following a dosage regimen providing a positive benefit-risk profile.</p>
申请公布号
AU2015101629(A4)
申请公布日期
2015.12.10
申请号
AU20150101629
申请日期
2015.11.06
申请人
NOVARTIS AG
发明人
BOULTON, CRAIG;BURTIN, PASCALE;DAVID, OLIVIER;DE VERA, ANA;DUMORTIER, THOMAS;HUNT, IRENE;SCHMOUDER, ROBERT
